Home
Conditions
Leukemia, Myeloid, Acute

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

NCT06680752

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Anemia, +12 more
Locations: Novant Health Cancer Institute Charlotte, North Carolina, United States

Novant Health Cancer Institute Winston-Salem, North Carolina, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

PTX3-targeted Antifungal Prophylaxis

NCT03828773

Conditions: Acute Myeloid Leukemia, Aspergillosis, Bacterial Infections and Mycoses, +17 more
Locations: Ghent University Hospital Ghent, Belgium

AZ Sint-Jan Hospital Bruges, Belgium

University Hospital Leuven (UZ Leuven) Leuven, Belgium

Henri Mondor Hospital Créteil, Île-de-France Region, France

View Trial Details

Recruiting

Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

NCT06782971

Conditions: AML - Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Canberra Health Services Canberra, Australian Capital Territory, Australia

Prince of Wales Hospital Sydney, New South Wales, Australia

Royal North Shore Hospital Sydney, New South Wales, Australia

Westmead Hospital Westmead, New South Wales, Australia

View Trial Details

Recruiting

Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.

NCT06022016

Conditions: Bone Marrow Diseases, DDX41 Gene Mutation, Hematologic Diseases, +7 more
Locations: Chu de Bordeaux Bordeaux, France

Chu de Limoges Limoges, France

Institut Paoli-Calmettes Marseille, France

Chu de Montpellier Montpellier, France

View Trial Details

Recruiting

Study Investigating the Safety of CD19 CAR-T Cells in Relapsed/Refractory AML Expressing CD19

NCT06649227

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU de Lille Lille, France

View Trial Details

Recruiting

Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

NCT07263906

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: The Second Affiliated Hospital,School of Medicine,Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

NCT03300492

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: University Hospital Basel Basel, Switzerland

View Trial Details

Recruiting

Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation

NCT07256210

Conditions: Acute Lymphoblastic T-cell Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +15 more
Locations: Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology Moscow, Russia

View Trial Details

Recruiting

Correlation of Venetoclax Plasma Concentrations With Toxicity of Hypometilating Agents and Venetoclax Combination for Acute Myeloid Leukemia Patients in Remission.

NCT07254312

Conditions: AML (Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Fondazione IRCCS Policlinico San Matteo, SC Oncologia Pavia, Italy

View Trial Details

Recruiting

OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia

NCT06377579

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Amiens CHU Amiens, France

Angers CHU Angers, France

Bayonne CH Bayonne, France

Besançon CHU Besançon, France

View all 21 locations

View Trial Details

Leukemia, Myeloid, Acute

Leukemia, Myeloid, Acute trial results

Related conditions